Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fusobacterium nucleatum outer membrane porin FomA is the primary major outer membrane protein (MOMP) of the Gram-negative anaerobe Fusobacterium nucleatum [1]. It functions as a non-specific porin, forming a 16-stranded beta-barrel structure that facilitates the passive diffusion of small hydrophilic solutes across the outer membrane [2]. Beyond its transport role, FomA acts as a critical adhesin, mediating the co-aggregation of F. nucleatum with other oral bacteria such as Streptococcus species, which is essential for dental plaque biofilm development [3]. In the context of disease, F. nucleatum is strongly associated with periodontitis and the progression of colorectal cancer, where FomA contributes to the bacterium's ability to colonize and persist in the host environment [4]. Research has identified FomA as a promising vaccine candidate due to its high expression and surface exposure, with studies demonstrating that immunization can elicit protective antibody responses [5]. Currently, there are no approved drugs specifically targeting FomA, but it remains a focal point for developing targeted antimicrobials and diagnostic tools for Fusobacterium-associated pathologies [6].
None currently approved; experimental approaches focus on vaccine-induced antibody production to neutralize bacterial colonization or the use of inhibitors to disrupt adhesion and membrane permeability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fusobacterium nucleatum outer membrane porin FomA (FomA).